跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE
Approved
STANDARD
NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE
Evolus Pharma B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 25, 2022
Approval ID
2dd2190e76bafd02
Company
Evolus Pharma B.V.
Type
Standard
Approval Details
Approval Id
2dd2190e76bafd02
Drug Cima Aemps Name
NUCEIVA 50 UNIDADES POLVO PARA SOLUCIÓN INYECTABLE
Register Number
1191364002
Holder Company Name
Evolus Pharma B.V.
Marketing Company Name
Evolus Pharma Limited
Holder Company Detail Path
/organization/evolus-pharma-bv
Authorization Date
2022-02-25
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE
Dose
50 Unidades
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Evolus Pharma B.V.
Company Detail Path
/organization/evolus-pharma-bv
Company Information
Pharmaceutical Company Name
Evolus Pharma BV
Country Name
Netherlands
Active Ingredients
TOXINA BOTULINICA TIPO A
50 U
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 25, 2022
Approval ID
2dd2190e76bafd02
Type
Standard
Back to CIMA-AEMPS Approvals
